在功能性便秘中,腹部图因和莫萨普里德酸盐的比较疗效:一项临床试验
Xiaoyu Shi1, Lingyun Shi1, Yukui Tian2
1Department of Spinal Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China.
腹部图因和莫萨普里德酸盐片有效治疗功能性便秘 (FC),改善症状和生活质量. 两种治疗方法在90天内表现出类似的疗效和安全性,在第10天发现了益处.
科学领域:
- 胃肠病学 胃肠病学
- 综合医学是一个整体的医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 功能性便秘 (FC) 是一种影响患者幸福感的常见疾病.
- 目前针对FC的治疗方法具有不同的疗效和副作用概况.
研究的目的:
- 为了比较"腹部tuina"的有效性和安全性与口服莫萨普里德酸盐片用于功能性便秘.
- 评估这些治疗对临床症状,生活质量和生化标志物的影响.
主要方法:
- 九十名患有FC的患者被随机分为两个组:"腹部图纳"或莫萨普里德酸盐片.
- 包括症状得分,生活质量和生化指标在内的结果在90天的时间内进行了评估.
主要成果:
- "腹部图纳"和莫萨普里德酸盐都显著改善了FC症状和生活质量.
- 早在第10天就观察到改善,并在整个研究过程中持续存在.
- 在这两种治疗中都没有报告任何显著的不良反应.
结论:
- "腹部图纳"和莫萨普里德酸盐片在治疗功能性便秘方面同样有效和安全.
- 这两种干预措施都为减少FC症状和提高患者生活质量提供了可行的选择.
更多相关视频
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
08:24Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models
Published on: August 11, 2023
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
Adsorbents...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
